a division of Ajinomoto OmniChem. Visit our other business units : AminoScience Division | Tensiofix | Natural Specialities

The Power to Make

Leading the way for 40 years in Pharmaceutical Fine Chemicals.


Ajinomoto Group Acquires All Shares of GeneDesign, a Nucleic Acid Drug CDMO, to Accelerate Expansion of the Contract Business for Oligonucleotides.

Read more ...